2,3-dihydroxybenzoic acid has been researched along with aniracetam in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Himori, N; Suzuki, T; Ueno, K | 1 |
1 other study(ies) available for 2,3-dihydroxybenzoic acid and aniracetam
| Article | Year |
|---|---|
Aniracetam, a pyrrolidinone-type cognition enhancer, attenuates the hydroxyl free radical formation in the brain of mice with brain ischaemia.
Topics: Animals; Brain; Brain Ischemia; Chromatography, High Pressure Liquid; Disease Models, Animal; Dopamine; Hydroxybenzoates; Hydroxyl Radical; Injections, Intraperitoneal; Male; Mice; Pyrrolidinones; Reperfusion Injury | 1995 |